Your Shopping Cart you currently have 0 item in your shopping cart Home  |  Overview  |  Features  |  Reviews  |  Test Yourself  |  Useful Links  |  About Us  |  Terms
Drugs in Context Drugs in Context
Drugs in Context
Search The Site
International Edition Drugs in Context
US Edition Drugs in Context
Drugs in Context Trials Drugs in Context
Drugs in Context Guidelines Drugs in Context
Translations Drugs in Context
Subscriptions Drugs in Context
Subscribers
email address
password
  
Drugs in Context Activate
Drugs in Context Forgotten Password
Drugs in Context
Drugs in Context
  New Issue Alert
  Contact Us
  Pass It On
Drugs in Context
Drugs in Context
Drugs in Context
Drugs in Context
Drugs in Context
Drugs in Context Drugs in Context Drugs in Context
Drugs in Context
Drugs in Context Publication Reviews Drugs in Context
Drugs in Context Feedback from our readers is very important to us and will help us to continually refine and develop Drugs in Context. If you have comments for us then please contact us.

The following quotes were provided by healthcare professionals who have read the books.

"I would read it and keep it."

"I thought the format was excellent, I liked the colour."

"I liked the idea of both specialist and GP input."

"It would influence my practice in an area that I was unsure of."

"It’s the independence that’s so important."

"I liked the fact that it covered basics and more complex issues - something for everyone."

"Generally very good quality."

"It’s in depth."

"I liked the summaries."

"It is not prescriptive which is useful."

"It’s very good - I would read it."

"I thought it was very good."

"Being free from NHS, Government and pharma is important."

"Independent, good referenced pieces are second to none for doctor information."

"I really liked the format."

"The colour figures were good."

"Genuinely well presented."

"The drug review will be useful to have as a reference."

Drugs in Context
Drugs in Context
Drugs in Context
Drugs in Context Drugs in Context
New
NICE guidelines on peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
NICE guidelines on peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
More Info
Editorial Summary
[MORE]
Drugs in Context
Drugs in Context
Drugs in Context Accepts Switch Visa and Mastercard © Copyright 2009 Drugs In Context is published by CSF Medical Communications Ltd
Secure online transactions made possible by HSBC